AMN Healthcare's (AMN) New Tie-Up to Boost Patient Outcome
https://www.zacks.com/stock/news/2195558/amn-healthcare-s-amn-new-tie-up-to-boost-patient-outcome?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195558
Dec 08, 2023 - AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.
0
Guidewire (GWRE) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
https://www.zacks.com/stock/news/2195547/guidewire-gwre-q1-earnings-revenues-beat-estimates-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2195547
Dec 08, 2023 - Guidewire's (GWRE) first-quarter performance benefits from higher subscription and support revenues.
0
Gear Up for ABM Industries (ABM) Q4 Earnings: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2195521/gear-up-for-abm-industries-abm-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2195521
Dec 08, 2023 - Beyond analysts' top -and-bottom-line estimates for ABM Industries (ABM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2023.
0
Morgan Stanley ups bluebird to equal weight ahead of FDA decision
https://seekingalpha.com/news/4044752-morgan-stanley-ups-bluebird-to-equal-weight-ahead-of-fda-decision?source=feed_sector_healthcare
Dec 08, 2023 - Morgan Stanley raised bluebird bio's (BLUE) rating to equal weight ahead of an expected FDA decision on its sickle cell disease gene therapy. Read more here.
0
Marriott (MAR) Ramps Up Luxury Portfolio With New Hotels
https://www.zacks.com/stock/news/2195340/marriott-mar-ramps-up-luxury-portfolio-with-new-hotels?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2195340
Dec 08, 2023 - Marriott (MAR) focuses on expanding its global luxury footprint to drive growth. The company reveals its 500th luxury hotel opening with The St. Regis Riyadh.
0
Pick Up in Service Sector Activity a Boon for These 5 Stocks
https://www.zacks.com/stock/news/2195300/pick-up-in-service-sector-activity-a-boon-for-these-5-stocks?cid=CS-ZC-FT-analyst_blog|investment_ideas-2195300
Dec 08, 2023 - With the service sector activity picking up in recent times, it's worth placing bets on stocks such as Barrett Business Services (BBSI), Shift4 Payments (FOUR), Carrols Restaurant Group (TAST), Brown & Brown (BRO) and Limbach (LMB).
0
'Excess profits' at big energy and consumer companies pushed up inflation, report claims
https://www.cnbc.com/2023/12/08/excess-profits-of-big-firms-have-driven-up-inflation-report-claims.html
Dec 07, 2023 - The report identified Shell, Exxon Mobil, Glencore and Kraft Heinz as among the firms that saw profits "far outpace" inflation.
0
Why did Walgreens Boots stock go up today? CVS 2024 guidance
https://seekingalpha.com/news/4044586-why-did-walgreens-boots-stock-go-up-today-cvs-2024-guidance?source=feed_sector_healthcare
Dec 07, 2023 - Walgreens Boots Alliance (WBA) gains as CVS Health's (CVS) bullish 2024 guidance boosts the drug store industry. Read more here.
0
Pharvaris (PHVS) Stock Up 18% on HAE Drug Meeting Study Goal
https://www.zacks.com/stock/news/2195115/pharvaris-phvs-stock-up-18-on-hae-drug-meeting-study-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195115
Dec 07, 2023 - Data from a mid-stage study shows that treatment with Pharvaris' (PHVS) investigational HAE drug reduced the monthly attack rate by 84.5%.
0
Lovesac (LOVE) Q3 Earnings & Revenues Beat Estimates, Up Y/Y
https://www.zacks.com/stock/news/2195107/lovesac-love-q3-earnings-revenues-beat-estimates-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2195107
Dec 07, 2023 - Lovesac's (LOVE) third-quarter fiscal 2024 results benefit from its highly-productive omnichannel footprint and product innovation.
0